Media coverage
6
Media coverage
Title Vaxalto Biotherapeutics and Mount Sinai Enter into Exclusive License Agreement for the Development and Commercialization of Novel Immunotherapeutic Oncolytic Viruses for Treatment of Cancer Media name/outlet PR Newswire European (Top News) Country/Territory United Kingdom Date 4/03/21 Persons Mihaela Skobe, Peter Palese Title Vaxalto Biotherapeutics and Mount Sinai Enter into Exclusive License Agreement Media name/outlet Pharma Focus Asia Country/Territory India Date 4/03/21 URL https://www.pharmafocusasia.com/news/vaxalto-biotherapeutics-and-mount-sinai-enter-into-exclusive-license-agreement Persons Mihaela Skobe, Peter Palese Title Vaxalto Biotherapeutics and Mount Sinai Enter into Exclusive License Agreement for the Development and Commercialization of N... Media name/outlet ADVFN US Country/Territory United States Date 4/03/21 URL https://www.advfn.com/p.php?pid=nmona&article=84496951 Persons Mihaela Skobe, Peter Palese Title Vaxalto Biotherapeutics and Mount Sinai Enter into Exclusive License Agreement for the Development and Commercialization of Novel Immunotherapeutic Oncolytic Viruses for Treatment of Cancer Media name/outlet India Pharma News Country/Territory India Date 4/03/21 Persons Mihaela Skobe, Peter Palese Title Vaxalto Biotherapeutics collaborates with Mount Sinai Innovation Partners Media name/outlet M2 Pharma Country/Territory United States Date 4/03/21 Persons Mihaela Skobe Title Vaxalto Biotherapeutics collaborates with Mount Sinai Innovation Partners Media name/outlet M2Pharma.com Country/Territory United States Date 4/03/21 URL m2pharma.com/news/policy-and-regulations/article.php?id=90324 Persons Mihaela Skobe